Bay Capital Advisors, LLC

Position in JNJ — Johnson & Johnson

CIK 2055414 VIRGINIA BEACH, VA

Position in JNJ

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$220,953

+$20,268 QoQ

Shares Held

870

+6.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.40%

of 13F equity value

Holder Rank

#4,447

of 4,676 holders

Holding Since

Dec 2024

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Bay Capital Advisors, LLC holds $3,183,411 across 5 Drug Manufacturers - General names. JNJ ranks #4 (6.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,466	$1,758,364
2	ABBV	AbbVie Inc.	2,976	$748,880
3	AZN	Astrazeneca PLC	1,256	$238,162
4	JNJ	Johnson & Johnson This page	870	$220,953
5	GILD	Gilead Sciences, Inc.	1,718	$217,052

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$220,953	870	+6.0%	Shares	Sole	2026-07-21
2026-03-31	$200,685	821	-46.0%	Shares	Sole	2026-04-22
2024-12-31	$219,822	1,520	—	Shares	Sole	2025-02-12
No filing history on record for this holder in this stock.